Britain widens access to Pfizer's COVID-19 antiviral drug through trial - CNA

LONDON: Britain will expand access to Pfizer's oral antiviral COVID-19 treatment to thousands more people by adding it to a trial to assess how best to use the drug in its highly vaccinated population, the health ministry said on Tuesday (Apr 12). Paxlovid…

Britain has reported 170,000 deaths from COVID-19, and Prime Minister Boris Johnson has cited antivirals as part of his plan to learn to live with the virus, saying they can cut deaths among those wh… [+866 chars]

full article...